autologous dendritic cell-tumor cell fusion vaccine (Teikyo University)

N/A

Report date: 2025/03/18 20:00:05

Base Information

Drug Nameautologous dendritic cell-tumor cell fusion vaccine (Teikyo University)

Drug Alias NameN/A

ClassificationVaccines > Application > Therapeutic vaccineCell and gene therapy > Cell therapyVaccines > Development/production technology > Dendritic cell vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsGastrointestinal Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryJapan

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesTeikyo University

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesTeikyo University

Active IndicationsN/A

Inactive IndicationsGastrointestinal Neoplasms

Other Information

ATC CodeN/A